Abstract:Objective To study the long-term results of mechanical valve replacement, bioprosthetic valve replacement or valve plasty in elderly patients with mitral valve disease. Methods From January 2006 to December 2008, 116 cases, received mitral valve surgery and were discharged. Among all the patients, 76 cases suffered from rheumatic mitral valve disease, 40 cases suffering from mitral degenerative disease. Mechanical valve replacement was carried out in 62 cases, biological valve replacement in 34 cases and mitral valvuloplasty in 20 cases. The events of death, reoperation, infective endocarditis, paravalvular leakage, cardiac function, anticoagulation,bleeding events, thromboembolism were recorded by outpatient clinic interview or telephone follow-up. Results 116 patients were followed up for 24 to 60 months and the mean time of follow-up was 48.4 ± 10.7 months.During the follow-up, mitral valve function was good in 20 cases of valvuloplasty and there were no deaths, moderate regurgitation, readmission, reoperation, and other adverse events. Biological valves function were normal in 34 cases of biological valve replacement, and during follow-up period the poatieuts aspirin was used to prevent coagulation. There were no valve decline and no adverse events. The cardiac function was significantly improved. All 62 cases of mechanical valve replacement were taking warfarin with good mechanical valve function and the heart function improved significantly. The events of infective endocarditis, paravalvular leakage, bleeding and thromboembolism occured. Conclusions Surgical treatment of mitral valve disease in elderly patients could significantly improve cardiac function and prolong survival time. However, the long-term effects of different surgical procedures have some differences. Valvuloplasty could avoid the application of anticoagulation drugs. Biological valve replacement can be as good as valvuloplasty, but biological decay may lead to re-operation in the relatively low-age patients. Mechanical valve replacement requires lifelong anticoagulation therapy, and the main factors affecting the long-term effects are bleeding and thrombotic complications.

Fellow-up of Valve Operation:A Report of 917 Cases

Results of surgical treatment in valve disease in 70 patients

Valve Replacement for Valvular Heart Disease with Giant Left Ventricle.

Modifiable risk factors of immediate and long-term outcomes in the operable and inoperable with left-sided infective endocarditis

Perioperative Management of 310 High Risk Patients with Valvular Heart Disease

Clinical Study of the Efficacy of Different Types of Surgery in Elderly Patients with Mitral Valve Disease

Survival Correlates with Regurgitation Degree Before and After Invasive Atrioventricular Valve Treatment

Efficacy of Double Valve Replacement/Repair in Patients with Reduced Left Ventricular Ejection Fractions

20 Years of triple-valve surgery in the UK: demographic and outcome trends

Persistant Pupillary Membrane Surgery.

Surgical treatment of valve endocarditis in high-risk patients and predictors of long-term outcomes

Histochemical studies of striated muscle after temporary ischemia in the rat

Stability of employment after traumatic brain injury

Behavior of the thyroid toward elements of the seventh periodic group.

The Analysis of Reoperation after Mechanical Valve Prosthesis Replacement

Outcomes of Different Mitral Valve Approaches Combined with Aortic Valve Replacement in Patients with Degenerative Valve Disease

Long-term Outcomes Following Valve-Sparing Root Replacement with Concomitant Mitral Repair

Late results of mitral valve repair for mitral regurgitation due to degenerative disease

Measures to Reduce Early Rate of Death after Heart Valve Replacement

SURGICAL TREATMENT OF RHEUMATIC TRICUSPID DISEASE

LONG-TERM FOLLOW UP OF 351 CASES OF HEART VALVE REPLACEMENT WITH BIOPROSTHESES